P493 Comparison of the efficacy of infliximab biosimilar (Remsima®) vs. infliximab original (Remicade®) in patients with inflammatory bowel disease

Authors :: M Belvis Jimenez
T Valdes Delgado
R Perea Amarillo
Federico Argüelles-Arias
M F Guerra Veloz
V Merino
A. Benítez Roldán
Á Caunedo Álvarez
L Castro Laria
B Maldonado Pérez
Source :: Journal of Crohn's and Colitis. 12:S354-S355
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.

Subjects :: medicine.medical_specialty
business.industry
Gastroenterology
Biosimilar
General Medicine
medicine.disease
Inflammatory bowel disease
Infliximab
Internal medicine
medicine
In patient
business
medicine.drug

Full Text Access

Tools